JP2024156672A5 - - Google Patents
Info
- Publication number
- JP2024156672A5 JP2024156672A5 JP2024108581A JP2024108581A JP2024156672A5 JP 2024156672 A5 JP2024156672 A5 JP 2024156672A5 JP 2024108581 A JP2024108581 A JP 2024108581A JP 2024108581 A JP2024108581 A JP 2024108581A JP 2024156672 A5 JP2024156672 A5 JP 2024156672A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- substantially described
- novel products
- manufacturing methods
- manufacturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762563534P | 2017-09-26 | 2017-09-26 | |
| US62/563,534 | 2017-09-26 | ||
| JP2020538776A JP2020535232A (ja) | 2017-09-26 | 2018-09-26 | 透過エンハンサーを含む送達医薬組成物 |
| PCT/US2018/052927 WO2019067596A1 (en) | 2017-09-26 | 2018-09-26 | ADMINISTRATIVE PHARMACEUTICAL COMPOSITIONS CONTAINING PERMEATION PROMOTERS |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538776A Division JP2020535232A (ja) | 2017-09-26 | 2018-09-26 | 透過エンハンサーを含む送達医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024156672A JP2024156672A (ja) | 2024-11-06 |
| JP2024156672A5 true JP2024156672A5 (https=) | 2026-04-14 |
Family
ID=63858155
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538776A Pending JP2020535232A (ja) | 2017-09-26 | 2018-09-26 | 透過エンハンサーを含む送達医薬組成物 |
| JP2024108581A Pending JP2024156672A (ja) | 2017-09-26 | 2024-07-05 | 透過エンハンサーを含む送達医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538776A Pending JP2020535232A (ja) | 2017-09-26 | 2018-09-26 | 透過エンハンサーを含む送達医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20190091281A1 (https=) |
| EP (1) | EP3687508A1 (https=) |
| JP (2) | JP2020535232A (https=) |
| KR (1) | KR20200059269A (https=) |
| CN (1) | CN111148512A (https=) |
| BR (1) | BR112020005875A2 (https=) |
| CA (1) | CA3076751A1 (https=) |
| IL (2) | IL273477B2 (https=) |
| WO (1) | WO2019067596A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL313551A (en) * | 2017-09-27 | 2024-08-01 | Aquestive Therapeutics Inc | Enhanced delivery epinephrine and prodrug compositions |
| US11648197B2 (en) | 2018-06-28 | 2023-05-16 | Arx, Llc | Dispensing method for producing dissolvable unit dose film constructs |
| US12440472B2 (en) * | 2021-06-16 | 2025-10-14 | Intelgenx Corp. | Stable tryptamine oral films |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8620035D0 (en) * | 1986-08-18 | 1986-10-01 | Sandoz Ltd | Organic compounds |
| GB2193891B (en) * | 1986-08-18 | 1990-07-25 | Sandoz Ltd | Nasal pharmaceutical composition containing a somatostatin anologue. |
| US5879690A (en) * | 1995-09-07 | 1999-03-09 | Perricone; Nicholas V. | Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers |
| US20030124176A1 (en) * | 1999-12-16 | 2003-07-03 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
| US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US7666337B2 (en) | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| SE0302924D0 (sv) * | 2003-11-05 | 2003-11-05 | Camurus Ab | Pharmaceutical composition having a cationic excipient |
| US20110257096A1 (en) * | 2004-08-25 | 2011-10-20 | Aegis Therapeutics, Inc. | Compositions for drug administration |
| US20060073173A1 (en) * | 2004-10-04 | 2006-04-06 | Maria Banach | Large-scale manufacturing process for the production of pharmaceutical compositions |
| ZA200711040B (en) * | 2005-06-03 | 2009-04-29 | Acrux Dds Pty Ltd | Method and composition for transdermal drug delivery |
| WO2011071860A2 (en) | 2009-12-07 | 2011-06-16 | Alnylam Pharmaceuticals, Inc. | Compositions for nucleic acid delivery |
| GB2478849A (en) * | 2010-03-16 | 2011-09-21 | Chiasma Inc | Improved pharmecutical compositions and methods of delivery |
| IE20100174A1 (en) * | 2010-03-25 | 2012-02-29 | Trinity College Dublin | Transdermal administration of peptides |
| WO2012070028A1 (en) * | 2010-11-26 | 2012-05-31 | University Of The Witwatersrand, Johannesburg | A pharmaceutical dosage form |
| KR20150027831A (ko) * | 2012-07-06 | 2015-03-12 | 레오 파마 에이/에스 | 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물 |
| FR3013589B1 (fr) * | 2013-11-28 | 2017-03-31 | Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic | Composition d'alkyl polyglucosides et d'acides gras cationisees |
| US20170119660A1 (en) * | 2015-10-29 | 2017-05-04 | Solubest Ltd | Pharmaceutical compositions for transmucosal delivery |
-
2018
- 2018-09-26 EP EP18786579.5A patent/EP3687508A1/en active Pending
- 2018-09-26 CN CN201880062678.9A patent/CN111148512A/zh active Pending
- 2018-09-26 JP JP2020538776A patent/JP2020535232A/ja active Pending
- 2018-09-26 CA CA3076751A patent/CA3076751A1/en active Pending
- 2018-09-26 IL IL273477A patent/IL273477B2/en unknown
- 2018-09-26 BR BR112020005875-0A patent/BR112020005875A2/pt unknown
- 2018-09-26 IL IL311142A patent/IL311142A/en unknown
- 2018-09-26 WO PCT/US2018/052927 patent/WO2019067596A1/en not_active Ceased
- 2018-09-26 KR KR1020207011909A patent/KR20200059269A/ko active Pending
- 2018-09-26 US US16/143,036 patent/US20190091281A1/en active Pending
-
2024
- 2024-07-05 JP JP2024108581A patent/JP2024156672A/ja active Pending